About us

First Spanish Biotech Start-up at the Johnson & Johnson European Innovation Centre

Tetraneuroncorporate video

Our history

2012

Tetraneuron was founded

2013

Identification of therapeutic target. E2F4

2014

Beginning of the proof of concept

2015

Validation of therapeutic target: E2F4DN

2016

Identification of the Leading Compound

2017

Validation of the Leading Compound

2018

Validation of the Leading Compound

2019

Analysis of biological processes modulated by E2F4DN

2020

Method validation of AAV9-E2F4DN

2021

Beginning of preclinical regulatory Phase

JLABS

JLABS is a top-level biological science incubation programme, a global network of open innovation ecosystems that allows and trains innovators to create and speed up the delivery of health and well-being solutions that improve patients’ lives

JLABS – Johnson & Johnson Innovation

Since February, 2019 Tetraneuron is a resident company of Johnson&Johnson Innovation-JLABS at the head offices of Janssen Pharmaceutical in Beerse, Belgium.